Zuzanna Łukasik
- ORCID iD
-
0000-0001-9551-3578
Show
Sort by
-
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023 : that is the question
-
- Miscellaneous
- open access
GDF15 mediates inflammation-associated bone loss through a brain-bone axis
-
- Journal Article
- A1
- open access
Gut inflammation in axial spondyloarthritis patients is characterized by a marked type 17 skewed mucosal innate‐like T cell signature
-
Use of imaging in axial spondyloarthritis for diagnosis and assessment of disease remission in the year 2022
-
- Journal Article
- A1
- open access
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses : EAACI task force on eicosanoids consensus report in times of COVID-19
-
Progressive increase in sacroiliac joint and spinal lesions detected on magnetic resonance imaging in healthy individuals in relation to age
-
- Journal Article
- A1
- open access
Crossing the boundaries : IL-23 and its role in linking inflammation of the skin, gut and joints
-
- Journal Article
- A1
- open access
MAIT cells come to the rescue in cancer immunotherapy?